Reduction of corticosteroid use in outpatient treatment of exacerbated COPD - Study protocol for a randomized, double-blind, non-inferiority study, (The RECUT-trial)

Reduction of corticosteroid use in outpatient treatment of exacerbated COPD - Study protocol for a randomized, double-blind, non-inferiority study, (The RECUT-trial)

Abstract Background Chronic obstructive pulmonary disease (COPD) is a major public health issue affecting approximately 4% to 7% of the Swiss population. According to current inpatient guidelines, systemic corticosteroids are important in the treatment of acute COPD exacerbations and should be given...

Full description

Bibliographic Details
Main Authors: Pascal Urwyler, Maria Boesing, Kristin Abig, Marco Cattaneo, Thomas Dieterle, Andreas Zeller, Herbert Bachler, Stefan Markun, Oliver Senn, Christoph Merlo, Stefan Essig, Elke Ullmer, Jonas Rutishauser, Macé M Schuurmans, Joerg Daniel Leuppi
Format: Article
Language:English
Published: BMC 2019-12-01
Series:Trials
Subjects:
COPD
AECOPD
Exacerbation
Primary care
Corticosteroids
Online Access:https://doi.org/10.1186/s13063-019-3856-8

Internet

https://doi.org/10.1186/s13063-019-3856-8

Similar Items